Can biologics become more affordable without compromising quality or reliability?
During this year’s BIO International Convention, Dr. Adriana Kiędzierska-Mencfeld, CEO of Rezon Bio, presented a manufacturing case study exploring how systematic process optimization can drive significant improvements in productivity, execution reliability and cost efficiency in biologic drug substance manufacturing.
On-demand presentation: “Enabling affordable biologics through advanced process optimization: A manufacturing case study”
Key case study focus areas:
- Biologics affordability: Exploring the relationship between manufacturing performance, cost-efficiency and supply reliability.
- Process optimization: A real-world case study demonstrating measurable improvements in yield, consistency and process robustness.
- Data-driven execution: The role of process understanding, analytics, and cross-functional collaboration in performance improvement.
- Digital Twin technology: Testing and validating process changes in a virtual environment prior to implementation.
